- Home
- TWO vs LBPH Comparison
TWO vs LBPH Comparison
Compare TWO & LBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWO
- LBPH
- Stock Information
- Founded
- TWO 2009
- LBPH 2020
- Country
- TWO United States
- LBPH United States
- Employees
- TWO N/A
- LBPH N/A
- Industry
- TWO Real Estate Investment Trusts
- LBPH Biotechnology: Pharmaceutical Preparations
- Sector
- TWO Real Estate
- LBPH Health Care
- Exchange
- TWO Nasdaq
- LBPH Nasdaq
- Market Cap
- TWO 1.3B
- LBPH 1.4B
- IPO Year
- TWO 2009
- LBPH 2021
- Fundamental
- Price
- TWO $11.62
- LBPH $59.69
- Analyst Decision
- TWO Buy
- LBPH Buy
- Analyst Count
- TWO 8
- LBPH 8
- Target Price
- TWO $14.32
- LBPH $52.29
- AVG Volume (30 Days)
- TWO 1.4M
- LBPH 1.1M
- Earning Date
- TWO 10-28-2024
- LBPH 11-07-2024
- Dividend Yield
- TWO 15.50%
- LBPH N/A
- EPS Growth
- TWO N/A
- LBPH N/A
- EPS
- TWO N/A
- LBPH N/A
- Revenue
- TWO $119,476,000.00
- LBPH N/A
- Revenue This Year
- TWO N/A
- LBPH N/A
- Revenue Next Year
- TWO N/A
- LBPH N/A
- P/E Ratio
- TWO N/A
- LBPH N/A
- Revenue Growth
- TWO N/A
- LBPH N/A
- 52 Week Low
- TWO $11.28
- LBPH $3.60
- 52 Week High
- TWO $14.59
- LBPH $59.95
- Technical
- Relative Strength Index (RSI)
- TWO 33.87
- LBPH 79.25
- Support Level
- TWO $11.59
- LBPH $59.71
- Resistance Level
- TWO $11.77
- LBPH $59.87
- Average True Range (ATR)
- TWO 0.30
- LBPH 0.23
- MACD
- TWO 0.02
- LBPH -0.92
- Stochastic Oscillator
- TWO 23.45
- LBPH 76.99
About TWO Two Harbors Investment Corp
Two Harbors Investment Corp is a real estate investment trust primarily focused on investing in, financing, and managing residential mortgage-backed securities, or RMBS; residential mortgage loans; mortgage servicing rights; and commercial real estate. The majority of the company's investment portfolio is split between agency RMBS purchased from government-sponsored enterprises and nonagency RMBS. Two Harbors derives nearly all of its revenue in the form of interest income collected from its investments. Most of this income is generated by available-for-sale securities, while residential mortgage loans held for investment in securitization trusts also contribute a sizable amount.
About LBPH Longboard Pharmaceuticals Inc.
Longboard Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. The company is working to improve a portfolio of centrally acting product candidates designed to be selective for specific G protein-coupled receptors (GPCRs). The company is evaluating LP352, an oral, centrally acting 5-hydroxytryptamine 2C (5-HT2C) receptor superagonist, with negligible observed impact on 5-HT2B and 5-HT2A receptor subtypes, in development for the potential treatment of seizures associated with a broad range of developmental and epileptic encephalopathies.